Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for radiation or chemotherapy.
A Finnish population study shows that signs related to Alzheimer’s disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's disease could allow earlier detection of the disease. This would allow preventive treatment to be targeted at the right individuals while the disease is still at the mild stage.
A new study by the University of Turku and Turku University Hospital found that a significant proportion of Parkinson's disease diagnoses are later corrected. Up to one in six diagnoses changed after ten years of follow-up, and the majority of new diagnoses were made within two years of the original diagnosis.
A new diagnostic assay, developed by MSc Md. Ferdhos Khan in his PhD study, will help to more accurately distinguish patients with prostate cancer from those with benign prostatic hyperplasia.
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for cardiac troponins are an important cornerstone in the diagnostics of heart attack, but the result may be elevated also due to other transient or chronic conditions, such as renal insufficiency, atrial fibrillation or strenuous physical exercise. The new test may help in identifying myocardial infarction (MI) faster and more specifically and thus improve the treatment of MI patients.
– Developing new diagnostic methods for detection and treatment of various diseases are key objectives of the InFLAMES Research Flagship. Collaboration with companies is invaluable to achieve this goal. The next InFLAMES Corporate Corner discusses on how the University and companies are already facilitating the cooperation and what more is needed, both from us and the diagnostics companies, to make the process even smoother” says InFLAMES Project Manager Kaisa Hakkila.